Ascendis Pharma Receives Positive CHMP Opinion for TransCon™ PTH (palopegteriparatide) for Adults with Chronic Hypoparathyroidism
المصدر:
Nasdaq GlobeNewswire
/
14 سبتمبر 2023 11:22:57 America/Chicago
N/A
شارك على،